Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EPTG small weeee .009x.01
GAXY hmmmmmm interesting 2 yr chart
Agreed, sold 2/3 of my CYDF divy shares rec'd from PRXT today for .70. PRXT cheap here imho
PRXT .0085x.009 1x1, :)
PPMC .08x.10 2x1 :)
CIMK 1.49 x 1.50 :)
RLTR nice pick congrats!
RLTR Congrats all who are in.
ICTN they sure spread it out
EEVT like the 1 yr real co fwiw
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
POFG on watch here at .065x.07
Premier Organic Farms and U.S. Power Systems Announce Merger
DALLAS, June 20 /PRNewswire-FirstCall/ -- U.S. Power Systems, Inc. (UPWY), announced today that a stock exchange agreement between Premier Organic Farms Corporation ('Premier') and UPWY took place on June 7, 2006, in which U.S. Power acquired 100% of Premier's common stock in exchange for stock and other considerations in U.S. Power Systems, Inc.
(Photo: http://www.newscom.com/cgi-bin/prnh/20060620/DATU034LOGO )
On June 8, 2006, U.S. Power Systems, Inc. underwent a name change to Premier Organic Farms Group, Inc. (OTC Pink Sheets: POFG).
The company raises domestic fresh organic tilapia fish, organic butter/boston lettuce, and organic herbs for U.S. markets.
Premier will grow hydroponic organic butter/boston lettuce through an ecologically efficient program in conjunction with the tilapia aquaculture program utilizing fish water which contains effluent to fertilize and water the lettuce.
Tilapia fish has gained in popularity between 2000 and 2005. Tilapia sales increased by 226%, and moved from the tenth most popular to the fourth most popular fish in the United States. Premier will be able to produce a superior farm-raised organic tilapia to supply the ever expanding organic market.
In 2005, tilapia sales in the U.S. were $1.17 billion, or approximately 625 million pounds. By the year 2010, U.S. tilapia sales are expected to reach $10 billion. The popularity of tilapia is expected to continue increasing significantly according to the USDA Environmental Research Service.
http://www.premierorganicfarms.com
POFG
Chart -
Reminder: Check For: ---> Dilution - Splits - News
nice call !
PIVX :) bid ut .12x.13 1x3 fwiw
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
PIVX bid ut .12x.13 1x3 fwiw
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
prlo 'they' did it again :) to .29 this time :) unreal
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
Yep :) PHYH watching for a break in the .05 wall here
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
AMHD just gettin started i hope :)
CIBM .015x.018 stingy with shares
Agreed Jim, irritating
PCES wow fnally been a long wait :)
MIADF .141x.40
here's a spin to keep u rollin
Great news on PAIV
By: same53
03 Aug 2006, 06:30 PM EDT
Msg. 12326 of 12329
Jump to msg. #
Great News New Symbol
First when you do a Reverse there is a new series of stock issued that is where the name change comes in.
PAVC is going to be good for all of us beleive me on this.
I have been here for almost a year now.
Plus here is what is figured into this new Symbol PAVC
A/S 125 Million
O/S 25 Million
Which means the float will be around
Float 125 thousand
And it happens tommorow. If we close at .06 we are at $12.00 S/P. We move to a better exchange which will take some time.
What do you think the brokerage industry is thinking? To Bad for them they deserve what they get.
Now for the restricted Certs that are sent to us by the T/A everything stays the same. When you bring your restricted PAIV Cert to be certified the CUSIP# will show up due to the reverse Split and automatically decrease your total share amout.
If you have 1 million shares it will be 50, 000 shares.
IMO when the restriction is off under rule 144 with the percent you can sell according to the 144 Rule with the reverse that just happen all of the former restricted shares will be bought up in the open market.
So the two year limit will be a moot point at that time IMO.
http://ragingbull.lycos.com/mboard/boards.cgi?board=PAIV&read=12326
re ssvg tanked for some reason but haven't found it yet, please let me know if u find anything thx
u have a link to that? tia
POFG beat up fs play
Chart -
Reminder: Check For: ---> Dilution - Splits - News
>
SSVG .0151x.017 1x3 fwiw
SSVG what's up on this one today u still have some? tia
PAIV 1-200 rs less than 100 shares to be rounded up to 100 criminals
PAIV=WAFPOS criminals
MIADF .16 x .22 2x1 now. I'm holding as i think it could blow up with the rgt news about the 8k. Might check your math. Mine says ML Strategic Ltd actually paid about .266 a share for 52.9% of the stock. That leaves about 1.73 million in the float jmho
Clearant Expands Addressable Market for Orthopedic Allograft Surgeries to Include Both Soft Tissue and Bone Implants
New Products Expand Product Opportunities to Markets Generating More Than $350 Million in Sales from $100 Million Previously
Clearant, Inc. (OTCBB:CLRI) today announced that it has expanded its product portfolio of allograft implants available through its direct sales force to include Clearant Process(R) sterile soft tissue implants for allograft sport medicine surgeries. Clearant now offers its sterile implants for both soft tissue and cervical spinal bone allograft surgeries through its direct distribution channel. By expanding its direct distribution initiative to include both soft and cervical spinal bone implants, Clearant has increased its addressable market from $100 million or more per year (for cervical spinal implants) to $350 million or more per year (for both soft tissue and cervical spinal implants).
Clearant's implants are sterilized using the Clearant Process, which achieves a level of sterility equal to or greater than that of medical devices while achieving excellent post-surgical clinical outcomes as compared to standard allograft tissue implants. Clearant plans to continue adding additional products later this year, including lumbar spinal bone implants, to address a market of $750 million or more per year.
"Our expanded portfolio of products will now allow us to enter lucrative markets that were previously unavailable to us," said Clearant Chief Executive Officer Alain Delongchamp. "Based on our long-standing relationships with a growing number of sports medicine surgeons and the strong positive clinical results observed with Clearant Process sterile soft tissue implants, we are confident that we will be able to accelerate the sales cycle."